|
41 |
Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic HepatitisAlexandra Manchel1, Radhakrishnan Mahadevan2, Ramon Bataller3, Jan Hoek1, and Rajanikanth Vadigepalli1
|
|
42 |
Outcome of Targeting ATR in High Replication Stress Murine HCCFANG Jing1, HE Qiyuan1, PAN Long3, DONNE Romain 2, ARAUJO Joana 1, POPHILLAT Céline 1, KABORE Christelle 1, COUTY Jean-Pierre 1, ZUCMAN-ROSSI Jessica 3, LUJAMBIO Amaya 2, MORIZUR Séverine 1, and DESDOUETS Chantal 1
|
|
43 |
Exploring Aspirin's Role in Mitigating Liver Cancer Development: Insights from a NASH Mouse ModelNur Dianah Abu Bakar
|
|
44 |
CELL-TRANSPLANTATION-INDUCED REPROGRAMMING STATE IS ESSENTIAL FOR
HEPATOCYTE ENGRAFTMENTZhen Sun
|
|
45 |
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk alleleMélanie Kirchmeyer1, Anthoula Gaigneaux1, Florence A. Servais1, Anita Arslanow2,3, Markus Casper3, Marcin Krawczyk3, Frank Lammert3,4, and Iris Behrmann1
|
|
46 |
Development of a precision bio-printed liver tumour patient-derived organoid platformGayatri D Shirolkar1,6, Sara Pasic1,6, Jonathan Tibballs2,6, Shirley Go2,6, Rachel Way4,6, Michael Wallace2,5,6, Louise Winteringham3,6, Peter Leedman3,6, Janina EE Tirnitz-Parker1,3,6, and Benjamin J Dwyer1,6
|
|
47 |
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular CarcinomaYoshinobu Saito1, Ajay Nair1, Qiuyan Sun1, Marcella Steffani1, Kirk Wangensteen2, Andrea Califano1, and Robert Schwabe1
|
|
48 |
Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic targetMaría Luque-Tévar1,2, Carme Cucarella1,2, Marina Fuertes-Agudo1,2, Paloma Martín-Sanz2,3, and Marta Casado1,2
|
|
49 |
Identifying drivers of liver cancer using CRISPR activation screening in vivoAlexandra M Vázquez Salgado1, Markcus Lee1, Shirui He2, and Kirk J Wangensteen1
|
|
50 |
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 KnockoutFrederik Link1, Yujia Li1, Stefan Munker2,3, Zeribe Nwosu4, Weiguo Fan5, Honglei Weng1, Matthias Ebert1,6, Steven Dooley1, and Sai Wang1
|
|
51 |
Epigenetic regulation by UHRF1 in the aging liverYousra Ajouaou, Filippo Macchi, Shuang Wang, and Kirsten Sadler Edepli
|
|
52 |
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancerThomas Sorz1,2,3, Oleksandr Petrenko1,2,3, Benedikt Simbrunner1,2,3,4, Kerstin Zinober1,3,4, Georg Semmler1,4, Philipp Königshofer1,3,4, Christopher C Kaltenecker5, Frank P Assen6, Benedikt S Hofer1,2,3,4, Behrang Mozayani5, Renate Kain5, Wolfgang P Weninger6, Michael Trauner1, Philipp Schwabl1,2,3,4, and Thomas Reiberger1,2,3,4
|
|
53 |
Dysregulated sphingolipid metabolism in MASH-HCCHuiping Zhou, Jing Zeng, Derrick Zhao, Xuan Wang, and Phillip Hylemon
|
|
54 |
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafishElena Magnani, Charlene Chen, Filippo Macchi, Ian McBain, and Kirsten C Sadler
|
|
55 |
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosisThomas Sorz1,2,3, Benedikt Simbrunner1,2,3,4, Kerstin Zinober1,3,4, Georg Semmler1,4, Philipp Königshofer1,3,4, Christopher C Kaltenecker5, Oleksandr Petrenko1,2,3, Benedikt S Hofer1,2,3,4, Behrang Mozayani5, Vlad Taru1,3, Renate Kain5, Michael Trauner1, Matthias Mandorfer1,4, Philipp Schwabl1,2,3,4, and Thomas Reiberger1,2,3,4
|
|
56 |
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels Sukriti Baweja, P Debishree Subudhi, Chhagan Bihari, and Shiv Kumar Sarin
|
|
57 |
In Vivo Tracking and 3D Mapping of Cell Death during Liver Regeneration and CancerIvan Moya1,2 and Georg Halder2
|
|
58 |
Disease-specific human ECM composition and bioactivity in NASH liver fibrosisLisa Longato
|
|
59 |
Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune HepatitisSukriti Baweja, Swati Thangariyal, Chhagan Bihari, and Shiv K Sarin
|
|
60 |
Pathway analysis including miRNA function. Artemis G Hatzigeogriou, Spyros Tastsoglou, Giorgos Skoufos, Marios Miliotis, and Filippos Kardaras
|
